Coenzyme Q10 Biosynthesis Established in the Non-Ubiquinone Containing Corynebacterium glutamicum by Metabolic Engineering

Standard

Coenzyme Q10 Biosynthesis Established in the Non-Ubiquinone Containing Corynebacterium glutamicum by Metabolic Engineering. / Burgardt, Arthur; Moustafa, Ayham; Persicke, Marcus; Sproß, Jens; Patschkowski, Thomas; Risse, Joe Max; Peters-Wendisch, Petra; Lee, Jin-Ho; Wendisch, Volker F.

In: FRONT BIOENG BIOTECH, Vol. 9, 2021, p. 650961.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Burgardt, A, Moustafa, A, Persicke, M, Sproß, J, Patschkowski, T, Risse, JM, Peters-Wendisch, P, Lee, J-H & Wendisch, VF 2021, 'Coenzyme Q10 Biosynthesis Established in the Non-Ubiquinone Containing Corynebacterium glutamicum by Metabolic Engineering', FRONT BIOENG BIOTECH, vol. 9, pp. 650961. https://doi.org/10.3389/fbioe.2021.650961

APA

Burgardt, A., Moustafa, A., Persicke, M., Sproß, J., Patschkowski, T., Risse, J. M., Peters-Wendisch, P., Lee, J-H., & Wendisch, V. F. (2021). Coenzyme Q10 Biosynthesis Established in the Non-Ubiquinone Containing Corynebacterium glutamicum by Metabolic Engineering. FRONT BIOENG BIOTECH, 9, 650961. https://doi.org/10.3389/fbioe.2021.650961

Vancouver

Bibtex

@article{cadb10aef42646adb3b187c85ee12ee7,
title = "Coenzyme Q10 Biosynthesis Established in the Non-Ubiquinone Containing Corynebacterium glutamicum by Metabolic Engineering",
abstract = "Coenzyme Q10 (CoQ10) serves as an electron carrier in aerobic respiration and has become an interesting target for biotechnological production due to its antioxidative effect and benefits in supplementation to patients with various diseases. For the microbial production, so far only bacteria have been used that naturally synthesize CoQ10 or a related CoQ species. Since the whole pathway involves many enzymatic steps and has not been fully elucidated yet, the set of genes required for transfer of CoQ10 synthesis to a bacterium not naturally synthesizing CoQ species remained unknown. Here, we established CoQ10 biosynthesis in the non-ubiquinone-containing Gram-positive Corynebacterium glutamicum by metabolic engineering. CoQ10 biosynthesis involves prenylation and, thus, requires farnesyl diphosphate as precursor. A carotenoid-deficient strain was engineered to synthesize an increased supply of the precursor molecule farnesyl diphosphate. Increased farnesyl diphosphate supply was demonstrated indirectly by increased conversion to amorpha-4,11-diene. To provide the first CoQ10 precursor decaprenyl diphosphate (DPP) from farnesyl diphosphate, DPP synthase gene ddsA from Paracoccus denitrificans was expressed. Improved supply of the second CoQ10 precursor, para-hydroxybenzoate (pHBA), resulted from metabolic engineering of the shikimate pathway. Prenylation of pHBA with DPP and subsequent decarboxylation, hydroxylation, and methylation reactions to yield CoQ10 was achieved by expression of ubi genes from Escherichia coli. CoQ10 biosynthesis was demonstrated in shake-flask cultivation and verified by liquid chromatography mass spectrometry analysis. To the best of our knowledge, this is the first report of CoQ10 production in a non-ubiquinone-containing bacterium.",
author = "Arthur Burgardt and Ayham Moustafa and Marcus Persicke and Jens Spro{\ss} and Thomas Patschkowski and Risse, {Joe Max} and Petra Peters-Wendisch and Jin-Ho Lee and Wendisch, {Volker F}",
note = "Copyright {\textcopyright} 2021 Burgardt, Moustafa, Persicke, Spro{\ss}, Patschkowski, Risse, Peters-Wendisch, Lee and Wendisch.",
year = "2021",
doi = "10.3389/fbioe.2021.650961",
language = "English",
volume = "9",
pages = "650961",
journal = "FRONT BIOENG BIOTECH",
issn = "2296-4185",
publisher = "Frontiers Media S. A.",

}

RIS

TY - JOUR

T1 - Coenzyme Q10 Biosynthesis Established in the Non-Ubiquinone Containing Corynebacterium glutamicum by Metabolic Engineering

AU - Burgardt, Arthur

AU - Moustafa, Ayham

AU - Persicke, Marcus

AU - Sproß, Jens

AU - Patschkowski, Thomas

AU - Risse, Joe Max

AU - Peters-Wendisch, Petra

AU - Lee, Jin-Ho

AU - Wendisch, Volker F

N1 - Copyright © 2021 Burgardt, Moustafa, Persicke, Sproß, Patschkowski, Risse, Peters-Wendisch, Lee and Wendisch.

PY - 2021

Y1 - 2021

N2 - Coenzyme Q10 (CoQ10) serves as an electron carrier in aerobic respiration and has become an interesting target for biotechnological production due to its antioxidative effect and benefits in supplementation to patients with various diseases. For the microbial production, so far only bacteria have been used that naturally synthesize CoQ10 or a related CoQ species. Since the whole pathway involves many enzymatic steps and has not been fully elucidated yet, the set of genes required for transfer of CoQ10 synthesis to a bacterium not naturally synthesizing CoQ species remained unknown. Here, we established CoQ10 biosynthesis in the non-ubiquinone-containing Gram-positive Corynebacterium glutamicum by metabolic engineering. CoQ10 biosynthesis involves prenylation and, thus, requires farnesyl diphosphate as precursor. A carotenoid-deficient strain was engineered to synthesize an increased supply of the precursor molecule farnesyl diphosphate. Increased farnesyl diphosphate supply was demonstrated indirectly by increased conversion to amorpha-4,11-diene. To provide the first CoQ10 precursor decaprenyl diphosphate (DPP) from farnesyl diphosphate, DPP synthase gene ddsA from Paracoccus denitrificans was expressed. Improved supply of the second CoQ10 precursor, para-hydroxybenzoate (pHBA), resulted from metabolic engineering of the shikimate pathway. Prenylation of pHBA with DPP and subsequent decarboxylation, hydroxylation, and methylation reactions to yield CoQ10 was achieved by expression of ubi genes from Escherichia coli. CoQ10 biosynthesis was demonstrated in shake-flask cultivation and verified by liquid chromatography mass spectrometry analysis. To the best of our knowledge, this is the first report of CoQ10 production in a non-ubiquinone-containing bacterium.

AB - Coenzyme Q10 (CoQ10) serves as an electron carrier in aerobic respiration and has become an interesting target for biotechnological production due to its antioxidative effect and benefits in supplementation to patients with various diseases. For the microbial production, so far only bacteria have been used that naturally synthesize CoQ10 or a related CoQ species. Since the whole pathway involves many enzymatic steps and has not been fully elucidated yet, the set of genes required for transfer of CoQ10 synthesis to a bacterium not naturally synthesizing CoQ species remained unknown. Here, we established CoQ10 biosynthesis in the non-ubiquinone-containing Gram-positive Corynebacterium glutamicum by metabolic engineering. CoQ10 biosynthesis involves prenylation and, thus, requires farnesyl diphosphate as precursor. A carotenoid-deficient strain was engineered to synthesize an increased supply of the precursor molecule farnesyl diphosphate. Increased farnesyl diphosphate supply was demonstrated indirectly by increased conversion to amorpha-4,11-diene. To provide the first CoQ10 precursor decaprenyl diphosphate (DPP) from farnesyl diphosphate, DPP synthase gene ddsA from Paracoccus denitrificans was expressed. Improved supply of the second CoQ10 precursor, para-hydroxybenzoate (pHBA), resulted from metabolic engineering of the shikimate pathway. Prenylation of pHBA with DPP and subsequent decarboxylation, hydroxylation, and methylation reactions to yield CoQ10 was achieved by expression of ubi genes from Escherichia coli. CoQ10 biosynthesis was demonstrated in shake-flask cultivation and verified by liquid chromatography mass spectrometry analysis. To the best of our knowledge, this is the first report of CoQ10 production in a non-ubiquinone-containing bacterium.

U2 - 10.3389/fbioe.2021.650961

DO - 10.3389/fbioe.2021.650961

M3 - SCORING: Journal article

C2 - 33859981

VL - 9

SP - 650961

JO - FRONT BIOENG BIOTECH

JF - FRONT BIOENG BIOTECH

SN - 2296-4185

ER -